Valence 로고
인기
로그인
Loading data for OPTH — first visit, this takes a few seconds.

관심목록에 추가

Optimi Health Corp.

NasdaqCM: OPTH · 실시간 가격 · USD
4.78
+0.01 (0.21%)
종가 기준: Aug 18, 2026, 8:00 PM

Optimi Health Corp. (OPTH) Stock Price, Analysis & Data

0.21%

데이터 없음

매수호가n/a
시가총액27.37M
매출 (ttm)175.67K
순이익 (ttm)-6.9M
베타n/a
EPS (ttm)-1.45
P/E (ttm)n/a
선행 P/En/a
P/B (ttm)6.07
P/S (ttm)155.80
Earnings Daten/a
매도호가n/a
거래량45,933
평균 거래량 (20일)146,241
시가4.72
전일 종가4.77
일중 범위4.64 - 4.95
52주 범위4.00 - 6.40
애널리스트n/a
목표주가n/a
배당n/a
배당락일n/a

OPTH 소개

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical source...

[더 보기]
산업 Drug Manufacturers - Specialty & Generic
섹터 Healthcare
IPO 일자 May 20, 2026
직원 수 n/a
상장 거래소 NasdaqCM
티커 OPTH
웹사이트 https://www.optimihealth.ca
전체 기업 정보

재무 실적

2025년 Optimi Health의 매출은 426.3K로, 전년 389.85K 대비 9.35% 증가했습니다. 순이익은 -3.71M로, -38.5% 감소했습니다.

재무제표
news image

1일 전 · Market Exclusive

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Key Takeaways; Cannabis Sector Curaleaf Holdings Announced Intention to Launch a Hostile Takeover Bid to Acquire Aurora Cannabis Organigram Posted Record Quarter as Sanity Group Acquisition Fueled Glo...

news image

1개월 전 · Simply Wall St.

3 Psychedelic Stocks With Potential Clinical Trial Catalysts

Big pharma is funding a field it once dismissed. These three psychedelic stocks carry possible clinical catalysts as the healthcare industry turns to alternative medicines.

news image

2개월 전 · Simply Wall St.

Why Optimi’s Ibogaine Initiative Could Open a New Growth Channel

Optimi Health advances ibogaine strategy amid rising regulatory and research support.

news image

2개월 전 · MT Newswires

Optimi Health up 2.5% as It Completes Commercial 5mg Psilocybin Production Run

Optimi Health (OPTI.CN), up 2.5% on last look, on Tuesday said it completed a production run of its

news image

2개월 전 · Stocktwits

SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public – Here’s What Aided The Decision

SRx Health, which is merging with EMJ Crypto Technologies, said EMJ’s proprietary operating system used quantitative models and artificial intelligence to pick Optimi Health as an investment opportuni...